A Study to Evaluate Patient Experience and Satisfaction with Predictive Genomic Testing Ordered Through SL3


About this study

The purpose of this study is to better understand the impact of predictive genomic testing in the healthy adult population by assessing decisional satisfaction/regret, understanding of disease risk, lifestyle modifications, and satisfaction with the testing experience. 


Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Individuals who received results of predictive genomic testing through the SL3 clinic from 1/1/2017 to 6/30/2019.

Exclusion Criteria: 

  • Center for Individualized Medicine employees.
  • Non-English speaking patients.
  • Patients with no available email address.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Konstantinos Lazaridis, M.D.

Open for enrollment

Contact information:

Emily Lisi CGC, LCGC


More information


Publications are currently not available

Mayo Clinic Footer